Avalo Therapeutics
- Pharmaceutical Preparations
- Rockville, Maryland
Compensation history
Top executives at Avalo Therapeutics received an average of $1M per person in annual compensation from 2014 to 2022.
Average pay of disclosed executives at Avalo Therapeutics
By year
- 2022
GN$1MGarry NeilChief Executive Officer, President, Chairman of the Board and principal executive officerSS$991KStephen SmolinskiFormer Chief Commercial OfficerMC$945KMichael ColaFormer Chief Executive Officer and former principal executive officerCS$769KChristopher SullivanChief Financial Officer and principal financial officer- 2021
MC$3MMichael ColaFormer Chief Executive Officer and former principal executive officerSG$2MSchond GreenwayFormer Chief Financial Officer and former principal financial officerHW$1MH. Jeffrey WilkinsFormer Chief Medical OfficerGN$1MGarry NeilChief Executive Officer, President, Chairman of the Board and principal executive officerCS$628KChristopher SullivanChief Financial Officer and principal financial officer
Executives
We found 17 executives who work or worked at Avalo Therapeutics.
Garry Neil
Avalo Therapeutics
Chief Executive Officer
Christopher Sullivan
Avalo Therapeutics
Chief Financial Officer
Michael Cola
Avalo Therapeutics
Chief Executive Officer
Stephen Smolinski
Avalo Therapeutics
Former Chief Commercial Officer
Schond Greenway
Avalo Therapeutics
Chief Financial Officer
H Wilkins
Avalo Therapeutics
Chief Medical Officer
Joseph Miller
Avalo Therapeutics
Chief Financial Officer
Peter Greenleaf
Avalo Therapeutics
Chief Executive Officer
News
Avalo Therapeutics CEO Garry Neil's 2022 pay rises 8% to $1.3M
October 19, 2023
Avalo Therapeutics CEO Michael Cola's 2021 pay falls 29% to $2.7M
April 25, 2022
Avalo Therapeutics Chairman Simon Pedder's 2019 pay jumps 13,562% to $3.8M
April 28, 2020
Avalo Therapeutics CEO Peter Greenleaf's 2018 pay jumps 17,372% to $5.1M
June 19, 2019
About Avalo Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address540 Gaither Road, Suite 400, Rockville, Maryland 20850
- Phone410-522-8707
- Fiscal year endDecember 31
- Former names
- Cerecor Inc.Until August 17, 2021
Source: SEC filings on October 19, 2023, April 25, 2022, April 28, 2020, June 19, 2019, April 5, 2018, and April 8, 2016.